Therapeutic peptide production in Drosophila

► We developed a novel platform to produce biologically active peptides in Drosophila. ► As a proof-of-concept, biologically active human insulin was successfully produced. ► This method could provide an useful alternative to commercial peptide production. ► This also has the great potentials for the peptide drug development.